Get the Stockscreener App
6.55
0.91%
-0.06
After Hours:
6.55
Neuehealth Inc stock is traded at $6.55, with a volume of 4,066.
It is down -0.91% in the last 24 hours and down -3.82% over the past month.
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
See More
Previous Close:
$6.61
Open:
$6.6
24h Volume:
4,066
Relative Volume:
0.67
Market Cap:
$59.11M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.73%
1M Performance:
-3.82%
6M Performance:
-11.37%
1Y Performance:
+23.78%
1-Day Range:
$6.55
$6.61
1-Week Range:
$6.33
$6.7221
52-Week Range:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Name
Neuehealth Inc
Sector
Industry
Phone
612-238-1321
Address
9250 NW 36TH STREET, DORAL
Compare NEUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.55 | 59.29M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
299.84 | 279.39B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
70.82 | 89.00B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
304.57 | 79.63B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
310.00 | 69.65B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
290.00 | 34.54B | 123.11B | 1.58B | 2.44B | 13.03 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-22 | Downgrade | BofA Securities | Buy → Underperform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-10-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-12-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-02-21 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Upgrade | Citigroup | Neutral → Buy |
| Aug-04-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-19-21 | Initiated | Goldman | Buy |
| Jul-19-21 | Initiated | JP Morgan | Neutral |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | RBC Capital Mkts | Outperform |
| Jul-19-21 | Initiated | Wolfe Research | Peer Perform |
View All
Neuehealth Inc Stock (NEUE) Latest News
Short Covering May Lift NeueHealth Inc. in Near Term2025 Investor Takeaways & Risk Managed Investment Strategies - newsimpact.co.kr
What makes NeueHealth Inc. stock attractive todayWeekly Trend Summary & Target Return Focused Stock Picks - newsyoung.net
Is NeueHealth Inc. the Top Chart Pick This WeekPortfolio Return Report & Weekly Breakout Watchlists - metal.it
NeueHealth Stock Soars Toward 9-Month Highs On $1.3B Take-Private Deal: Retail Exuberant - MSN
What is the target price for NeueHealth Inc. stockStop Loss & Technical Entry and Exit Tips - 선데이타임즈
NeueHealth buys full ownership of Centrum Health - MSN
Is It Too Late to Sell NeueHealth Inc.2025 Price Action Summary & Long-Term Capital Growth Strategies - newsyoung.net
NeueHealth Inc’s Earnings Call Highlights Growth and Innovation - TipRanks
NeueHealth Inc. At Critical Juncture — Bounce or BreakdownJuly 2025 Final Week & Verified Swing Trading Watchlist - beatles.ru
Sector ETF Data Correlates with Strength in NeueHealth Inc.Market Growth Summary & Safe Swing Trade Setups - beatles.ru
How institutional ownership impacts NeueHealth Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Tools to assess NeueHealth Inc.’s risk profileTechnical Setup Guide for Daily Watchlist - Newser
What makes NeueHealth Inc. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Will NeueHealth Inc. price bounce be sustainableReal-Time Setup Summary with ROI Focus - Newser
NeueHealth signals ongoing growth with 45% increase in consumers served while expanding NeuePulse platform - MSN
Custom strategy builders for tracking NeueHealth Inc.Predictive Short-Term Market Reversal Alerts - Newser
Buy Signal for NeueHealth Inc. Stock Key Technical Indicators to WatchMomentum Prediction Based on AI Backtesting - Newser
What’s the recovery path for long term holders of NeueHealth Inc.ROI Focused Setup Screener With Exit Markers - Newser
Predicting NeueHealth Inc. trend using moving averagesFree Real Time Trade Opportunity Alerts - Newser
Chart overlay techniques for tracking NeueHealth Inc.Quarterly Investment Outlook and Key Summary - Newser
Will NeueHealth Inc. stock hit new highs in YEARVolume Surge With Low Float - thegnnews.com
NeueHealth Inc. Reports Strong Q2 2025 Results - The Globe and Mail
How high can NeueHealth Inc. stock goFree Smart Trend Trading with Weekly Signals - Newser
NeueHealth 2025 Q2 Earnings Strong Performance as Net Income Losses Drop 97.3% - AInvest
NeueHealth: Q2 Earnings Snapshot - Connecticut Post
NeueHealth Inc (NEUE) Q2 2025 Earnings Call Highlights: Sustained Profitability and Strategic ... By GuruFocus - Investing.com Canada
Tools to monitor NeueHealth Inc. recovery probabilityFree Stock Portfolio Allocation Guidance - Newser
NeueHealth's Q2 2025: Unraveling Contradictions in Growth Strategy, Financial Performance, and Acquisitions - AInvest
Transcript : NeueHealth, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Earnings call transcript: NeueHealth Q2 2025 sees steady growth amid strategic initiatives - Investing.com Canada
Earnings call transcript: NeueHealth Q2 2025 sees steady growth amid strategic initiatives By Investing.com - Investing.com South Africa
NeueHealth reports Q2 EPS ($2.62) vs. ($8.65) last year - TipRanks
NeueHealth, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
NeueHealth reports second quarter 2025 results - MarketScreener
NeueHealth Reports Second Quarter 2025 Results - TradingView
NeueHealth Q2 revenue up 45% YoY, serves 694k consumers. - AInvest
NeueHealth Inc. Flashes Rebound Signal in Oversold ConditionEntry Alert Based on Volume Spikes Detected - metal.it
Does NeueHealth Inc. stock perform well during market downturnsBuild wealth faster with consistent growth stocks - Jammu Links News
Should I hold or sell NeueHealth Inc. stock in 2025Capitalize on market trends with confidence - Jammu Links News
Is NeueHealth Inc. stock overvalued or undervaluedGet timely alerts on market opportunities - Jammu Links News
What are the latest earnings results for NeueHealth Inc.Expert guidance for superior capital growth - Jammu Links News
What is NeueHealth Inc. company’s growth strategyExplosive wealth accumulation - Jammu Links News
What drives NeueHealth Inc. stock priceBuild capital through low-risk investments - Jammu Links News
What analysts say about NeueHealth Inc. stockAccelerated wealth expansion - Jammu Links News
Is it the right time to buy NeueHealth Inc. stockDiscover undervalued stocks before they soar - Jammu Links News
What institutional investors are buying NeueHealth Inc. stockAccelerated earnings growth - Jammu Links News
Is NeueHealth Inc. a growth stock or a value stockExplosive earning power - Jammu Links News
Neuehealth Inc Stock (NEUE) Financials Data
There is no financial data for Neuehealth Inc (NEUE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.79%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):